Sevident Inc has developed a proprietary rapid cellular and molecular capture technology (NETs) that enables the capture and detection of a variety of targets without any sample preparation. The company was founded by Dr. Emily Ann Stein, a University of California, Berkeley trained microbiologist who holds multiple US and international patents regarding the composition of matter, design, methods of use and potential applications of NETs. Sevident's NETs has applications in R&D tools, Medical Diagnostics, Biologics Manufacturing, and Bio-Threat Surveillance and Screening. The company designs NETs for specific targets and capture agents based on client needs.
